
Few Kidney Patients Can Access Palliative Care or Hospice—Why?
Treatments that reduce suffering and incorporate patient values aren’t common in kidney disease care. That’s changing
Larry C. Price is a two-time Pulitzer Prize-winning documentary photographer and multimedia journalist based in Dayton, Ohio. He previously produced award-winning photography and video footage for Undark's Breathtaking series on air pollution, which won a George Polk Award for Environmental Reporting in 2018. Follow Larry C. Price on Twitter @larrycprice
Treatments that reduce suffering and incorporate patient values aren’t common in kidney disease care. That’s changing
Demand for healthy kidneys has long outstripped supply. But better testing and treatment are expanding the donor pool
Minority patients are diagnosed later, stay on dialysis longer and are added to transplant lists less quickly. Why?
Joint ventures between nephrologists and dialysis centers have expanded treatment. Critics ask: At what cost?
A new California law aims to curb what sponsors say is profiteering by dialysis centers. But are there any easy answers?
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account